» Authors » Duncan F Moore

Duncan F Moore

Explore the profile of Duncan F Moore including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 29
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu J, VanBuren J, Child A, Alvey J, Mandl L, Pinheiro L, et al.
J Rheumatol . 2025 Jan; 52(3):263-269. PMID: 39814444
Objective: We aimed to evaluate the psychometric properties of the Scleroderma Skin Questionnaire (SSQ), a novel patient-reported outcome (PRO) to assess systemic sclerosis (SSc)-related skin symptoms. Methods: Participants were recruited...
2.
Bass R, Moore D, Steen V
Arthritis Care Res (Hoboken) . 2023 Sep; 76(3):311-317. PMID: 37691427
Objective: There is limited literature describing the overlap of systemic sclerosis (SSc) and systemic lupus erythematosus (SLE), and the studies have employed a range of case definitions. Our study used...
3.
Luebker S, Frech T, Assassi S, Skaug B, Gordon J, Lakin K, et al.
Rheumatology (Oxford) . 2023 Apr; 62(10):3433-3438. PMID: 37079727
Objectives: SSc is associated with increased health-care resource utilization and economic burden. The Collaborative National Quality and Efficacy Registry (CONQUER) is a US-based collaborative that collects longitudinal follow-up data on...
4.
Moore D, Steen V
J Scleroderma Relat Disord . 2022 Apr; 6(1):3-10. PMID: 35382244
Systemic sclerosis is a highly morbid, complex autoimmune disease that is variable both in its phenotype and the attendant mortality driven by such manifestations. This review article synthesizes mortality data...
5.
Stephens M, Moore D, Dau J, Jobbagy S, Neel V, Bolster M, et al.
JAAD Case Rep . 2022 Mar; 23:20-23. PMID: 35308063
No abstract available.
6.
Moore D, Steen V
Rheum Dis Clin North Am . 2020 Sep; 46(4):705-712. PMID: 32981647
Racial and ethnic disparities in systemic sclerosis are abundant. The incidence, severity of end-organ manifestations, functional impairment, quality of life, and mortality of systemic sclerosis vary by ethnic group. This...
7.
Moore D, Kramer E, Eltaraboulsi R, Steen V
Arthritis Care Res (Hoboken) . 2019 Mar; 71(9):1154-1163. PMID: 30821906
Objective: African Americans with scleroderma have more severe disease and higher mortality than non-African Americans. Differences in rates of diffuse disease, autoantibody status, or socioeconomic status have not completely explained...